Sun, Jan 25, 2015, 7:33 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • system_architect_enterprise system_architect_enterprise Feb 1, 2013 7:06 AM Flag

    Juxtapid 2x as effective as Kynamro

    Wall Street Journal article yesterday pointed out that Juxtapid lowered cholesterol by half in 26 weeks versus Kynamro that only reduced cholesterol 25% over the same 26 weeks.

    They also cited Kynamro trying to offset their ineffectiveness with a lower price tag of $176,000 versus $235,000-295,000, though if you are dying and already paying a high price for meds, you probably are going to go for the most effective treatment you can. Especially considering Kynamro's links to causing cancer versus Juxtapid's clean safety profile.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
24.87+0.36(+1.47%)Jan 23 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.